Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BlackRock Kelso Capital CORP | 100 | reported | 03 Aug 2015 | tx 4+3,250 |
| ADiTx Therapeutics, Inc. | 0 | reported | 25 Nov 2025 | tx 7+353,922−1 |
1 purchase reported after at least 12 months of silence — most recent on 25 May 2021.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2025 | SALE | ADiTx Therapeutics, Inc. | 1 | 3.20 USD | |
| 08 Nov 2023 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 4,702 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 55,000 | 0.00 USD | |
| 25 May 2021 | PURCHASE | ADiTx Therapeutics, Inc. | 4,220 | 2.56 USD | first after silence |
| 24 Feb 2021 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 110,000 | 0.00 USD | |
| 02 Nov 2020 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 02 Nov 2020 | GRANT_AWARD | ADiTx Therapeutics, Inc. | 165,000 | 0.00 USD | deriv |
| 03 Aug 2015 | PURCHASE | BlackRock Kelso Capital CORP | 150 | 9.23 USD | |
| 03 Aug 2015 | PURCHASE | BlackRock Kelso Capital CORP | 1,000 | 9.24 USD | |
| 03 Aug 2015 | PURCHASE | BlackRock Kelso Capital CORP | 2,000 | 9.25 USD | |
| 03 Aug 2015 | PURCHASE | BlackRock Kelso Capital CORP | 100 | 9.24 USD |